Ronald Gross
Ophthalmology · Fairhope, ALNPI 1902890544
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $89,990 of the $142,874 with a category attached, or 63.0%. Aerie Pharmaceuticals, Inc. accounts for 61.8% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $91,109 and has fallen 99.8% since, to $163 in 2025. Among ophthalmology clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 200 payments — averaging $714.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aerie Pharmaceuticals, Inc.$88K
- AbbVie$47K
- Glaukos Corporation$7K
- Alcon$296
- NEW World Medical,inc.$276
- Cvrx, Inc.$150
- plus $273 from 4 others
Across 13 payments — averaging $8556.04 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$99K
- AbbVie$12K
What the payments were for
- Consulting fees$30,95022%
- Speaking & faculty fees$89,99063%
- Travel & lodging$17,62512%
- Food & beverage$4,3103%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aerie Pharmaceuticals, Inc. | 99 | $88,271 |
| AbbVie(2 entities) | 88 | $46,874 |
| Glaukos Corporation | 3 | $6,734 |
| Alcon | 2 | $296 |
| NEW World Medical,inc. | 2 | $276 |
| Cvrx, Inc. | 1 | $150 |
| Genentech, Inc. | 2 | $138 |
| Tearlab Corp | 1 | $96 |
| Tarsus Pharmaceuticals, Inc. | 1 | $21 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Rocklatan$86,696
- Rhopressa$67,560
- LUMIGAN$39,869
- COMBIGAN$19,864
- iStent inject Trabecular Micro-Bypass Stent System$6,600
- RESTASIS$5,000
- Clareon$153
- Barostim Neo System$150
- Hydrus Microstent$142
- iStent Trabecular Micro-Bypass System Model iS3$134
- XEN GLAUCOMA TREATMENT SYSTEM$118
How this compares
$142,874 in reported general payments places this provider in the 95th percentile of 197 ophthalmology providers in Alabama.
Other ophthalmology in Fairhope
- Bret FisherHomewood$545K
- Caroline WatsonHuntsville$292K
- Kristin BainsBirmingham$40K
- Sebastian HeersinkDothan$33K
- John ParkerVestavia$19K
- Lindsay RhodesBirmingham$18K
- Timothy JohnsonTuscaloosa$15K
- James LewisBirmingham$15K
- In ShinMontgomery$12K
- Harsha SenDothan$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.